Top compounds associated with response to HYPK


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.4
mRNA tivozanib CTRPv2 pan-cancer AAC -0.028 0.4
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.024 0.4
mRNA semagacestat CTRPv2 pan-cancer AAC -0.029 0.4
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.036 0.4
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.4
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.4
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.021 0.4
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC 0.052 0.4
mRNA SR8278 CTRPv2 pan-cancer AAC 0.097 0.4
Download CSV